Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 3/20 | 0.55 |
| ▸ | S1PR2 | O95136 | 1/20 | 0.52 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.52 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.52 |
| ▸ | S1PR5 | Q9H228 | 1/20 | 0.52 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.48 |
| ▸ | GGPS1 | O95749 | 4/20 | 0.47 |
| ▸ | FDPS | P14324 | 1/20 | 0.47 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.47 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.47 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.47 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.46 |
| ▸ | KDM5A | P29375 | 3/20 | 0.44 |
| ▸ | KDM4C | Q9H3R0 | 3/20 | 0.44 |
| ▸ | KDM5C | P41229 | 1/20 | 0.44 |
| ▸ | KDM5B | Q9UGL1 | 1/20 | 0.44 |
| ▸ | PHF8 | Q9UPP1 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | THRB | P10828 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11870492 | 0.97 | DNM1 (0.60) | DNM1S1PR2S1PR1S1PR3S1PR5 | |
| SCHEMBL22654 | 0.97 | DNM1 (0.60) | DNM1S1PR2S1PR1S1PR3S1PR5 | |
| SCHEMBL117987 | 0.97 | DNM1 (0.60) | DNM1S1PR2S1PR1S1PR3S1PR5 | |
| SCHEMBL20298464 | 0.97 | DNM1 (0.60) | DNM1S1PR2S1PR1S1PR3S1PR5 | |
| SCHEMBL4869710 | 0.97 | DNM1 (0.60) | DNM1S1PR2S1PR1S1PR3S1PR5 | |
| SCHEMBL516694 | 0.97 | DNM1 (0.60) | DNM1S1PR2S1PR1S1PR3S1PR5 | |
| SCHEMBL8625464 | 0.97 | DNM1 (0.60) | DNM1S1PR2S1PR1S1PR3S1PR5 | |
| SCHEMBL15407868 | 0.97 | DNM1 (0.60) | DNM1S1PR2S1PR1S1PR3S1PR5 | |
| Hydrochloric Acid SCHEMBL22771820 | 0.97 | DNM1 (0.57) | DNM1S1PR2S1PR1S1PR3S1PR5 | |
| SCHEMBL15535338 | 0.97 | DNM1 (0.60) | DNM1S1PR2S1PR1S1PR3S1PR5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 73 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-106745845-A | A kind of Seawater Treatment antisludging agent and preparation method thereof | 江苏经纬技术创新咨询有限公司 | 2017-05-31 | — | — | CN | claimed |
| WO-2008109780-A1 | METHODS AND COMPOUNDS FOR THE TARGETED DELIVERY OF AGENTS TO BONE FOR INTERACTION THEREWITH | UNIVERSITY OF LOUISVILLE RESEARCH FOUNDATION, INC (US) | 2008-09-12 | — | — | WO | claimed |
| US-20080221070-A1 | METHODS AND COMPOUNDS FOR THE TARGETED DELIVERY OF AGENTS TO BONE FOR INTERACTION THEREWITH | UNIVERSITY OF LOUISVILLE RESEARCH FOUNDATION | 2008-09-11 | — | — | US | claimed |
| EP-0850086-A1 | DEVICE FOR THE IONTOPHORETIC ADMINISTRATION OF BISPHOSPHONATES | Becton, Dickinson and Company (US) | 1998-07-01 | — | — | EP | claimed |
| US-5730715-A | BONE DISORDERS | BECTON DICKINSON AND COMPANY (US) | 1998-03-24 | — | — | US | claimed |
| WO-1997047356-A1 | DEVICE FOR THE IONTOPHORETIC ADMINISTRATION OF BISPHOSPHONATES | BECTON, DICKINSON AND COMPANY (US) | 1997-12-18 | — | — | WO | claimed |
| WO-2023189799-A1 | SELF CROSS-LINKABLE POLYMER AND RESIST UNDERLAYER FILM-FORMING COMPOSITION | 日産化学株式会社 | 2023-10-05 | — | — | WO | disclosed |
| WO-2022261235-A1 | NON-PEPTIDE TARGETED THERAPEUTICS AND USES THEREOF | Crinetics Pharmaceuticals, Inc. (US) | 2022-12-15 | — | — | WO | disclosed |
| US-20220340570-A1 | IRAK DEGRADERS AND USES THEREOF | KYMERA THERAPEUTICS, INC. | 2022-10-27 | — | — | US | disclosed |
| US-20190248881-A1 | TGF-ß RECEPTOR FUSION PROTEINS AND OTHER TGF-ß ANTAGONISTS FOR REDUCING TGF-ß SIGNALING | PRECITHERA, INC. (CA) | 2019-08-15 | — | — | US | disclosed |
| EP-3509156-A1 | ELECTROLYTE SOLUTION | DAIKIN INDUSTRIES, LTD. (JP) | 2019-07-10 | — | — | EP | disclosed |
| EP-2631980-B1 | NON-AQUEOUS ELECTROLYTE SOLUTION | DAIKIN IND LTD (JP) | 2017-10-11 | — | — | EP | disclosed |
| US-9745302-B2 | 10H-benzo[g]pteridine-2,4-dione derivatives, method for the production thereof, and use thereof | TRIOPTOTEC GMBH (DE) | 2017-08-29 | — | — | US | disclosed |
| US-7214818-B2 | Method for synthesizing bisphosphonate | HOFFMANN-LA ROCHE INC. (US) | 2007-05-08 | — | — | US | disclosed |
| EP-0850086-A1 | DEVICE FOR THE IONTOPHORETIC ADMINISTRATION OF BISPHOSPHONATES | Becton, Dickinson and Company (US) | 1998-07-01 | — | — | EP | disclosed |
| US-5730715-A | BONE DISORDERS | BECTON DICKINSON AND COMPANY (US) | 1998-03-24 | — | — | US | disclosed |
| WO-1997047356-A1 | DEVICE FOR THE IONTOPHORETIC ADMINISTRATION OF BISPHOSPHONATES | BECTON, DICKINSON AND COMPANY (US) | 1997-12-18 | — | — | WO | disclosed |
| EP-0052016-B1 | CARBOSTYRIL COMPOUNDS, COMPOSITIONS CONTAINING SAME AND PROCESSES FOR PREPARING SAME | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1984-09-05 | — | — | EP | disclosed |
| US-4414390-A | CARDIOTONIC AGENTS | OTSUKA, PHARMACEUTICAL CO., LTD. (JP) | 1983-11-08 | — | — | US | disclosed |
| EP-0052016-A1 | Carbostyril compounds, compositions containing same and processes for preparing same | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1982-05-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080221070-A1 | METHODS AND COMPOUNDS FOR THE TARGETED DELIVERY OF AGENTS TO BONE FOR INTERACTION THEREWITH | SHBG, ESRRA, ESRRG | DNM1 1865/4885S1PR2 928/4885S1PR1 981/4885 |
| US-20220340570-A1 | IRAK DEGRADERS AND USES THEREOF | IRAK2, IRAK3, IRAK1 | DNM1 4044/4885S1PR2 2608/4885S1PR1 2230/4885 |
| US-20190248881-A1 | TGF-ß RECEPTOR FUSION PROTEINS AND OTHER TGF-ß ANTAGONISTS FOR REDUCING TGF-ß SIGNALING | TGFBR1, TGFBR2, SMAD2 | DNM1 561/4885S1PR2 1933/4885S1PR1 1748/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.